2018
DOI: 10.1053/j.gastro.2017.11.102
|View full text |Cite
|
Sign up to set email alerts
|

P064 Interferon-Gamma Induced Vascular Impairment Contributes to the Pathogenesis of Inflammatory Bowel Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…IFN-γ blockade in dextran sodium sulfate-colitis mouse models had increased angiogenesis accompanied with improved vascular barrier function and reduced colonic inflammation [ 112 ]. Fontolizumab, an anti-IFN-γ antibody, increased the rate of clinical response in individuals with refractory CD, after receiving two doses of fontolizumab intravenously on Day 56 [ 113 ].…”
Section: Cytokine-targeted Therapies In Ibdmentioning
confidence: 99%
“…IFN-γ blockade in dextran sodium sulfate-colitis mouse models had increased angiogenesis accompanied with improved vascular barrier function and reduced colonic inflammation [ 112 ]. Fontolizumab, an anti-IFN-γ antibody, increased the rate of clinical response in individuals with refractory CD, after receiving two doses of fontolizumab intravenously on Day 56 [ 113 ].…”
Section: Cytokine-targeted Therapies In Ibdmentioning
confidence: 99%